Matthew Botein
About Matthew B. Botein
Matthew B. Botein (age 52) has served as an independent director of James River Group Holdings, Ltd. since January 2023. He is co‑founder and Managing Partner of Gallatin Point Capital LLC (since 2017), with prior roles as co‑head and CIO of BlackRock Alternative Investors (2009–2017) and advisor to BAI (2017–2020). He previously held senior investing roles at Highfields Capital Management and worked in the private equity groups at The Blackstone Group and Lazard Frères & Co. LLC. He holds a BA (magna cum laude) from Harvard College and an MBA (with high distinction; Baker and Loeb scholarships) from Harvard Business School .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Gallatin Point Capital LLC | Managing Partner, Co‑founder | 2017–present | Investor; sponsor of JRVR Series A Preferred; nomination designation right |
| BlackRock Alternative Investors | Co‑head & CIO (Alternatives); Advisor | 2009–2017 (Co‑head & CIO); 2017–2020 (Advisor) | Led alternatives investing; capital markets expertise |
| Highfields Capital Management | Managing Director, Mgmt Committee | Not disclosed | Investment management; governance exposure |
| The Blackstone Group | Private Equity Department | Not disclosed | PE skillset; M&A execution |
| Lazard Frères & Co. LLC | Private Equity Department | Not disclosed | Transaction experience |
External Roles
| Organization | Role | Public/Private | Tenure/Notes |
|---|---|---|---|
| Bowhead Specialty Holdings (NYSE: BOW) | Director | Public | Current |
| Northeast Bancorp (Nasdaq: NBN) | Director | Public | Current |
| Israel Discount Bank of New York | Director | Private | Current |
| Fortuna Holdings Limited (parent of Canopius) | Director | Private | Current |
| Tower Hill Risk Management, LLC | Director | Private | Current |
| Trusted Resource Underwriters Exchange (TRUE) | Director | Private | Current |
| Insurance Supermarket, Inc. | Director | Private | Current |
| Prior public boards (selected): PFSI, AHL, CLGX, FAF, PMT | Director | Public | Past service |
| Beth Israel Lahey (formerly CareGroup/CJP) | Board of managers | Non‑profit | Current |
Board Governance
- Independence: The Board determined Botein is independent under Nasdaq standards, explicitly considering Gallatin Point’s current and prior relationships with JRVR .
- Committee assignments: Chair, Investment Committee (with D. Langwell as member); Investment Committee met two in‑person times in 2024 and oversees implementation of JRVR’s investment policy . Not currently on Audit or Compensation committees; he served on the Compensation and Human Capital Committee for part of 2024 .
- Board activity: In 2024 the Board held four in‑person meetings; all directors attended at least 75% of Board and committee meetings they served on. JRVR also held informational videoconferences between meetings .
- AGM engagement: All nominees for re‑election attended the 2024 annual meeting .
Fixed Compensation
JRVR excludes the Gallatin Point‑designated director (Botein) from director compensation under the Investment Agreement; he received no cash retainer or equity grants for 2024.
| Component | Standard Director Terms | Chair Premiums | Botein (2024) |
|---|---|---|---|
| Annual cash retainer | $125,000 paid quarterly | Audit Chair: +$25,000; Comp Chair: +$12,500; Nominating Chair: +$12,500 | $0 (no compensation) |
| Annual RSU grant | $50,000 grant‑date fair value (vests in 1 year) | Board Chair RSU: $100,000 | $0 (no compensation) |
| 2024 actuals (cash/equity/dividends) | See director table (e.g., Brown: $150,000 cash; $50,000 RSUs; $402 dividends) | Chair in 2024 (Sherman): $125,000 cash; $99,999 RSUs; $1,043 dividends | “—” (no amounts) |
Performance Compensation
Directors receive service‑based RSUs; no performance‑based equity (PSUs) or options for directors under the Non‑Employee Director Plan.
| Element | Structure | Metrics/Targets | Vesting |
|---|---|---|---|
| Service‑based RSUs (Directors) | Annual grant at $50k FV; Chair $100k; pro‑rated for mid‑year directors | None (service‑based only) | Full vest on first anniversary of grant (1 year) |
| 2024 RSU grants | 5,102 RSUs to standard directors; 10,204 RSUs to Board Chair; 4,460 RSUs pro‑rated for LaSala | N/A | 1 year from grant |
| Options | Not part of Non‑Employee Director Plan; company option timing policy noted for executives | N/A | N/A |
Other Directorships & Interlocks
- JRVR Compensation Committee interlocks: In 2024, Botein, LaSala, Migliorato, Sherman (former Chair), and Roberts (former Chair) served during portions of the year. No JRVR executive officer served on any board or compensation committee of an entity with executives serving on JRVR’s Board/Compensation Committee (no cross‑interlocks) .
Expertise & Qualifications
- Board skills: Botein identified with strengths in corporate governance, executive leadership, business operations, finance/capital management, investments, and M&A (Board skills matrix) .
- Financial acumen: Investment management and investment banking experience; public company board experience; insurance industry knowledge .
Equity Ownership
JRVR discloses substantial beneficial ownership by the “GPC Parties” (including GPC Thames, Gallatin Point, Botein and Sachs), with a 9.9% voting cap on Series A Preferred and as‑converted voting power.
| Holder | Common Shares Beneficially Owned | % of Common | Series A Preferred Shares | % of Series A | Voting Power Limitation |
|---|---|---|---|---|---|
| GPC Parties (incl. Botein) | 19,381,009 | 32.6% | 112,500 | 100% | Series A votes as‑converted but capped at 9.9%; aggregate voting power equals 4,402,053 common shares |
- Share ownership guidelines: Non‑employee directors must reach 3x annual cash retainer within five years; Botein’s beneficial ownership via GPC far exceeds typical guideline thresholds .
Related Party Exposure and Conflicts
- Investment Agreement (Feb 24, 2022): JRVR issued 150,000 Series A perpetual cumulative convertible preferred shares to GPC Thames for $150M; agreement grants GPC Thames the right to designate one Board nominee (Botein) while holding ≥50% of as‑converted stake and ≥5% of common on an as‑converted basis .
- Amendment (Nov 11, 2024): Gallatin Point exchanged 37,500 Series A for 5,859,375 common shares at $6.40; optional conversion price reduced to $8.32; dividend fixed at 7% until Sept 30, 2029 then resets (5‑yr UST + 5.2%, max 8.0%); registration rights provided .
- Governance mitigants: Series A votes with common on an as‑converted basis but GPC’s voting capped at 9.9% of aggregate voting power, irrespective of economic stake .
Governance Assessment
- Alignment: Strong skin‑in‑the‑game through GPC’s 32.6% beneficial stake; Botein receives no JRVR director pay per Investment Agreement, reducing cash conflicts .
- Effectiveness: Chairs the Investment Committee overseeing portfolio policy; Board confirms his independence under Nasdaq despite sponsor affiliation; Board/committee meeting cadence and ≥75% attendance threshold met in 2024 .
- RED FLAGS:
- Sponsor‑designation right and registration rights coupled with large economic stake present potential conflict and influence risks; monitor transactions with Gallatin Point and conversions/dividends on Series A .
- Concentrated ownership (economic) despite 9.9% voting cap; continue monitoring for changes to voting rights or conversion limitations .
- Net view: Governance structure acknowledges and partially mitigates sponsor‑related conflicts via independence assessment, voting caps, and no director compensation for Botein; investors should track related‑party items, Investment Committee oversight quality, and any changes to preferred terms.
Appendix: Key Quantitative Disclosures
| Metric | Value | Source |
|---|---|---|
| Board meetings (2024) | 4 in‑person | Proxy 2025 |
| Investment Committee meetings (2024) | 2 in‑person | Proxy 2025 |
| Non‑employee director cash retainer | $125,000 per year | Proxy 2025 |
| Audit Chair cash | +$25,000 | Proxy 2025 |
| Compensation Chair cash | +$12,500 | Proxy 2025 |
| Nominating Chair cash | +$12,500 | Proxy 2025 |
| Standard director RSU FV | $50,000; vests in 1 year | Proxy 2025 |
| Board Chair RSU FV | $100,000; vests in 1 year | Proxy 2025 |
| 2024 RSU grants (standard) | 5,102 RSUs each | Proxy 2025 |
| 2024 RSU grants (Chair) | 10,204 RSUs | Proxy 2025 |
| 2024 RSU grants (LaSala pro‑rata) | 4,460 RSUs | Proxy 2025 |
| Botein director compensation (2024) | $0 (no cash/equity) | Proxy 2025 |
| GPC Parties common shares | 19,381,009 | Proxy 2025 |
| Common shares outstanding | 45,922,507 (Sep 3, 2025) | Proxy 2025 |
| Series A outstanding | 112,500 (Sep 3, 2025) | Proxy 2025 |
| Voting cap equivalent | 4,402,053 common shares | Proxy 2025 |
| Series A issuance price | $1,000/share; $150M total | Proxy 2025 |
| 11/11/2024 exchange | 37,500 Series A → 5,859,375 common @ $6.40 | Proxy 2025 |
| Conversion price | $8.32 after amendment | Proxy 2025 |
| Dividend rate | 7% to 9/30/2029; reset 5‑yr UST+5.2%, cap 8% | Proxy 2025 |
| Director ownership guideline | 3× annual cash retainer within 5 years | Proxy 2025 |